Leveraging CRISPR loss-of-function screens for interpretable and robust drug response prediction
Dom Kirkham, Sach Mukherjee, Oscar M. Rueda
Creating low-dimensional representations of cancer omics data, informed by large scale CRISPR screens, to improve robustness and interpretability in downstream tasks